BIOPHARMACEUTICAL INNOVATION SYSTEM IN CHINA: SYSTEM EVOLUTION AND POLICY TRANSITIONS (PRE-1990S-2010S)

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

HU HAO; CHUNG CHAO CHEN

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: AMIRKABIR Year:2015 | Volume:4 | Issue:12 Page(s): 823-829

Download Full-Text

View:

510

Download:

156

Cites:

Information Journal Paper

Title

BIOPHARMACEUTICAL INNOVATION SYSTEM IN CHINA: SYSTEM EVOLUTION AND POLICY TRANSITIONS (PRE-1990S-2010S)

Author(s)

HU HAO | CHUNG CHAO CHEN | Issue Writer Certificate

Keywords

BIOPHARMACEUTICAL

SECTORAL INNOVATION SYSTEM (SIS)

CHINA

PHARMACEUTICAL INDUSTRY

BIOTECHNOLOGY

Abstract

Background: This article sets up the initial discussion of the evolution of BIOPHARMACEUTICAL innovation in CHINA through the perspective of sectoral innovation system (SIS).Methods: Two data sources including archival documentary data and field interviews were used in this study. Archival documentary data was collected from CHINA Food and Drug Administration (CFDA) and Chinese National Knowledge Infrastructure (CNKI). In addition, industrial practitioners and leading researchers in academia were interviewed.Results: BIOPHARMACEUTICAL in CHINA was established through international knowledge transfer. The firms played more active role in commercializing BIOPHARMACEUTICAL in CHINA though universities and research institutes were starting to interact with local firms and make contribution to BIOPHARMACEUTICAL industrialization. The transition of the Chinese government’s policies continuously shapes the evolution of BIOPHARMACEUTICAL sector. Policies have been dramatic changes before and after 1980s to encourage developing BIOPHARMACEUTICAL as a competitive industry for CHINA.Conclusion: A SIS for BIOPHARMACEUTICAL has been shaped in CHINA. However, currently BIOPHARMACEUTICAL is still a small sector in CHINA, and for the further growth of the industry more synthetic policies should be implemented. Not only the policy supports towards the research and innovation of BIOPHARMACEUTICALs in the early stage of development should be attended, but also commercialization of BIOPHARMACEUTICAL products in the later stage of sales.

Cites

No record.

References

No record.

Cite

APA: Copy

HU, HAO, & CHUNG, CHAO CHEN. (2015). BIOPHARMACEUTICAL INNOVATION SYSTEM IN CHINA: SYSTEM EVOLUTION AND POLICY TRANSITIONS (PRE-1990S-2010S). AMIRKABIR, 4(12), 823-829. SID. https://sid.ir/paper/338224/en

Vancouver: Copy

HU HAO, CHUNG CHAO CHEN. BIOPHARMACEUTICAL INNOVATION SYSTEM IN CHINA: SYSTEM EVOLUTION AND POLICY TRANSITIONS (PRE-1990S-2010S). AMIRKABIR[Internet]. 2015;4(12):823-829. Available from: https://sid.ir/paper/338224/en

IEEE: Copy

HAO HU, and CHAO CHEN CHUNG, “BIOPHARMACEUTICAL INNOVATION SYSTEM IN CHINA: SYSTEM EVOLUTION AND POLICY TRANSITIONS (PRE-1990S-2010S),” AMIRKABIR, vol. 4, no. 12, pp. 823–829, 2015, [Online]. Available: https://sid.ir/paper/338224/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops